TP53 and nasopharyngeal carcinoma: Therefore, we investigated the effects of PinX1, miR-200b, and P53 on EMT in nasopharyngeal CD133+ CSCs, aiming to provide new therapeutic targets to prevent distant metastasis and NPC progression.